Literature DB >> 23016638

The physiological characteristics and transcytosis mechanisms of the blood-brain barrier (BBB).

Elizabeth C M de Lange1.   

Abstract

The blood-brain barrier (BBB) is the vessel wall made up of specialized capillary endothelial cells, surrounded by astroglial endfeet and neurons, that govern the exchange of compounds between blood and brain. It protects the brain from harmful compounds potentially present in blood, while it is specifically designed to supply the brain with the required nutrients and to get rid of waste products. The BBB is structurally different from blood capillaries in other tissues. The BBB strictly limits the paracellular exchange of compounds by the so-called tight junctions. Moreover, the capillary endothelial cells contain metabolic enzymes that may convert a compound before entering the brain while transcellular passage across the BBB may be limited or increased by active transport systems. Thus the BBB has an important role in the relationship of the concentration-time profile of compounds in blood and those in the brain. The functionality of the BBB is dynamically regulated, depending on the given conditions. Important examples are changes in BBB functionality that may result in or are brought about by (CNS) disease conditions. All together this indicates the importance of investigations on BBB functionality and resulting transport of compounds for the design and optimization of therapeutic regimens. Thus, BBB investigation is an ever growing and dynamic field studied by pharmacologists, neuroscientists, pathologists, physiologists, and clinical practitioners. This review deals with a general introduction on the physiological characteristics of the BBB, its different transport systems, with particular emphasis on supposed transcytosis mechanisms at the BBB. Specific and detailed information on drug delivery approaches aiming at transcytosis into the brain will be dealt with in other parts of this special issue.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23016638     DOI: 10.2174/138920112803341860

Source DB:  PubMed          Journal:  Curr Pharm Biotechnol        ISSN: 1389-2010            Impact factor:   2.837


  10 in total

1.  In Vitro Models of the Blood-Brain Barrier.

Authors:  Snehal Raut; Aditya Bhalerao; Behnam Noorani; Luca Cucullo
Journal:  Methods Mol Biol       Date:  2022

Review 2.  A new look at transudation: the apocrine connection.

Authors:  R Farkaš; M Beňo; D Beňová-Liszeková; I Raška; O Raška
Journal:  Physiol Res       Date:  2020-03-23       Impact factor: 1.881

3.  The mastermind approach to CNS drug therapy: translational prediction of human brain distribution, target site kinetics, and therapeutic effects.

Authors:  Elizabeth Cm de Lange
Journal:  Fluids Barriers CNS       Date:  2013-02-22

4.  The Extension of the LeiCNS-PK3.0 Model in Combination with the "Handshake" Approach to Understand Brain Tumor Pathophysiology.

Authors:  Makoto Hirasawa; Mohammed A A Saleh; Elizabeth C M de Lange
Journal:  Pharm Res       Date:  2022-03-07       Impact factor: 4.580

5.  Impact of CNS Diseases on Drug Delivery to Brain Extracellular and Intracellular Target Sites in Human: A "WHAT-IF" Simulation Study.

Authors:  Mohammed A A Saleh; Elizabeth C M de Lange
Journal:  Pharmaceutics       Date:  2021-01-13       Impact factor: 6.321

Review 6.  An Overview of Nanotechnologies for Drug Delivery to the Brain.

Authors:  Ahsan Ayub; Shawn Wettig
Journal:  Pharmaceutics       Date:  2022-01-19       Impact factor: 6.321

7.  Choroid sprouting assay: an ex vivo model of microvascular angiogenesis.

Authors:  Zhuo Shao; Mollie Friedlander; Christian G Hurst; Zhenghao Cui; Dorothy T Pei; Lucy P Evans; Aimee M Juan; Houda Tahiri; Houda Tahir; François Duhamel; Jing Chen; Przemyslaw Sapieha; Sylvain Chemtob; Jean-Sébastien Joyal; Lois E H Smith
Journal:  PLoS One       Date:  2013-07-26       Impact factor: 3.240

Review 8.  State of the art in the studies on crotamine, a cell penetrating peptide from South American rattlesnake.

Authors:  Irina Kerkis; Mirian A F Hayashi; Alvaro R B Prieto da Silva; Alexandre Pereira; Paulo Luiz De Sá Júnior; Andre J Zaharenko; Gandhi Rádis-Baptista; Alexandre Kerkis; Tetsuo Yamane
Journal:  Biomed Res Int       Date:  2014-01-15       Impact factor: 3.411

Review 9.  Theranostic quantum dots for crossing blood-brain barrier in vitro and providing therapy of HIV-associated encephalopathy.

Authors:  Gaixia Xu; Supriya Mahajan; Indrajit Roy; Ken-Tye Yong
Journal:  Front Pharmacol       Date:  2013-11-15       Impact factor: 5.810

10.  Characterization of Cationic Bolaamphiphile Vesicles for siRNA Delivery into Tumors and Brain.

Authors:  Taejin Kim; Mathias Viard; Kirill A Afonin; Kshitij Gupta; Mary Popov; Jacqueline Salotti; Peter F Johnson; Charles Linder; Eliahu Heldman; Bruce A Shapiro
Journal:  Mol Ther Nucleic Acids       Date:  2020-03-04       Impact factor: 8.886

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.